Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019:1989:55-81.
doi: 10.1007/978-1-4939-9454-0_5.

Scalable Conjugation and Characterization of Immunoglobulins with Stable Mass Isotope Reporters for Single-Cell Mass Cytometry Analysis

Affiliations

Scalable Conjugation and Characterization of Immunoglobulins with Stable Mass Isotope Reporters for Single-Cell Mass Cytometry Analysis

Felix J Hartmann et al. Methods Mol Biol. 2019.

Abstract

The advent of mass cytometry (CyTOF®) has permitted simultaneous detection of more than 40 antibody parameters at the single-cell level, although a limited number of metal-labeled antibodies are commercially available. Here we present optimized and scalable protocols for conjugation of lanthanide as well as bismuth ions to immunoglobulin (Ig) using a maleimide-functionalized chelating polymer and for characterization of the conjugate. The maleimide functional group is reactive with cysteine sulfhydryl groups generated through partial reduction of the Ig Fc region. Incubation of Ig with polymer pre-loaded with lanthanide ions produces metal-labeled Ig without disrupting antigen specificity. Antibody recovery rates can be determined by UV spectrophotometry and frequently exceeds 60%. Each custom-conjugated antibody is validated using positive and negative cellular control populations and is titrated for optimal staining at concentrations ranging from 0.1 to 10 μg/mL. The preparation of metal-labeled antibodies can be completed in 4.5 h, and titration requires an additional 3-5 h.

Keywords: Antibody; Bismuth; Conjugation; CyTOF; IgG; Immunoglobulin; Isotope; Lanthanide; Mass cytometry; Titration.

PubMed Disclaimer

Conflict of interest statement

Competing Financial Interests

S.C.B. and E.F.S. have been paid consultants for the company Fluidigm Sciences, the manufacturers that produced some of the reagents and instrumentation described in this manuscript.

Figures

Figure 1 –
Figure 1 –
Sources of signal interference in mass cytometry assays as demonstrated by analyzing a mixture of metal standard (139La, 141Pr, 159Tb, 169Tm, and 175Lu) on a CyTOF mass cytometer. (A) Spectral overlap from the 169 Tm standard into the 170 Er measurement channel. 169 Tm is naturally mono-isotopic with no expectation of a constituent with mass 170. (B) Natural Lu, used to make the standard in this experiment, contains ~99% 175 Lu and 1% 176 Lu. A distinct peak corresponding to the 176 Lu isotopic ‘contaminant’ can be seen in the measurement window that would be used for 176 Yb labeled reagents (red arrow). The dashed black boxes in (A) and (B) represent the measurement window where all signals within that range would be attributed to the indicated elemental isotope. (C) La and Pr oxide formation indicated with the blue and red arrows, respectively. Here the resulting ‘+16Da’ oxide interference peak is indicated with a ‘*’ of a matching color.
Figure 2 –
Figure 2 –
A workflow summarizing the timing and coordination of steps for the conjugation of a purified immunoglobulin with a sulfhydryl reactive polymer pre-loaded with metal isotope reporters.
Figure 3 –
Figure 3 –
Anticipated results for the titration of metal reporter conjugated antibodies by CyTOF mass cytometry. Using the protocol described herein, antibodies against human CD95, CD21, and CD14 were labeled with 164Dy, 152Sm, and 148Nd, respectively. Using the surface staining protocol and a methanol permeabilization, these antibodies were simultaneously titrated from 0.25–8 μg/ml on human peripheral blood mononuclear cells that were counterstained with CD45-154Sm, CD3-170Er, CD20-147Sm, CD33-158Gd, and CD16-165Ho in order to identify positive and negative cell populations. (A) From data analysis at cytobank.org, the following populations were identified: 1) CD33-positive myeloid cells, 2) CD20-positive B cells, 3) CD3-positive T cells, and 4) CD16-positive NK cells. (B) Histogram overlays of CD95, CD21, and CD14 expression levels in the gated populations from (A) were created at cytobank.org. Histogram color scale indicates minimum (black) and maximum (yellow) median counts for each given antibody. (C) Dot plots summarizing the median counts of representative positive (blue) and negative (red) cell controls for each of the titrated antibodies across the range of 0.25–8 μg/ml. In (B) and (C) the red asterisk indicates the ideal antibody concentration with maximum signal-to-noise (the ratio of positive control to negative control signal) and lowest antibody concentration where the positive signal begins to saturate.

References

    1. Baranov VI, Quinn Z, Bandura DR, Tanner SD (2002) A Sensitive and Quantitative Element-Tagged Immunoassay with ICPMS Detection. Anal Chem 74:1629–1636. doi: 10.1021/ac0110350 - DOI - PubMed
    1. Bandura DR, Baranov VI, Ornatsky OI, et al. (2009) Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry. Anal Chem 81:6813–6822. doi: 10.1021/ac901049w - DOI - PubMed
    1. Bendall SC, Simonds EF, Qiu P, et al. (2011) Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332:687–96. doi: 10.1126/science.1198704 - DOI - PMC - PubMed
    1. Bodenmiller B, Zunder ER, Finck R, et al. (2012) Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 30:858–67. doi: 10.1038/nbt.2317 - DOI - PMC - PubMed
    1. Behbehani GK, Bendall SC, Clutter MR, et al. (2012) Single-cell mass cytometry adapted to measurements of the cell cycle. Cytom Part A 81 A:552–566. doi: 10.1002/cyto.a.22075 - DOI - PMC - PubMed

Publication types